Ratings Fujimi Incorporated

Equities

5384

JP3820900003

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-01 am EDT			5-day change	1st Jan Change
3,445 ^JPY	0.00%		+6.66%	+9.89%

Feb. 02	Fujimi Incorporated Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024	CI
2023	Fujimi Incorporated Revises Earnings Guidance for Fiscal Year 2024	CI

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The group's high margin levels account for strong profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
With an expected P/E ratio at 40.17 and 28.5 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
With an enterprise value anticipated at 4.37 times the sales for the current fiscal year, the company turns out to be overvalued.
The company appears highly valued given the size of its balance sheet.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
FUJIMI INCORPORATED	+9.89%	1.62B	-
ECOLAB INC.	+14.02%	64.66B	A-
SIKA AG	-3.80%	46.08B	A-
GIVAUDAN SA	+13.26%	39.72B	B+
FUJIFILM HOLDINGS CORPORATION	+19.28%	25.82B	A-
EMS-CHEMIE HOLDING AG	+8.22%	18.8B	C+
CELANESE CORPORATION	-1.13%	17.14B	B+
POSCO FUTURE M CO., LTD.	-21.03%	15.86B	A-
SYMRISE AG	+1.06%	15.05B	B+
ALBEMARLE CORPORATION	-16.73%	14.14B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes